(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine (Paroxetine Impurity)

Catalog No. :
ACGWNF756
CAS No. :
110429-36-2
Molecular Formula :
C20H22FNO3
Molecular Weight :
343.40

IUPAC Name:(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine

(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine  (Paroxetine Impurity) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine (Paroxetine Impurity)
IUPAC Name(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-1-methylpiperidine
MDL No.MFCD03788781
Molecular FormulaC20H22FNO3
Molecular Weight343.40
SMILESCN1CC[C@@H](C2=CC=C(F)C=C2)[C@H](COC2=CC=C3OCOC3=C2)C1
InChI KeyMOJZPKOBKCXNKG-YJBOKZPZSA-N
SynonymAKOS015851047 | CS-0165673 | SMR000469181 | T71590 | N-Methyl Paroxetine | 4 7-DIMETHOXY-1-INDANONE 97 | (3S,4R)-3-((BENZODIOXOL-5-YLOXY)METHYL)-4-(4-FLUOROPHENYL)-1-METHYLPIPERIDINE | (3S,4R)-N-Methylparoxetine | CS-W007107 | J-002423 | Piperidine, 3-[(1
CAS No.110429-36-2
PubChem CID10947895

Synthetic Route by SureRoute

1. ACGWNF756 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACISZQ329 route compound structure diagram
    ACISZQ329533-31-3 In Stock
  4. Then
  5. ACGWNF756 route product structure diagram
    ACGWNF756110429-36-2
Inquiry

2. ACGWNF756 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWVNQ372 route compound structure diagram
    ACWVNQ37261869-08-7 In Stock
  4. Then
  5. ACGWNF756 route product structure diagram
    ACGWNF756110429-36-2
Inquiry

Comments (0)